Soluble TIM-3 levels were significantly higher in patients with SLE (2123 pg/mL (IQR, 229–7235)) than those in HCs (1363 pg/mL; IQR, 1097–1673; p = 0.0015; Figure 1). This evidence concerns the gene HAVCR2 and systemic lupus erythematosus.